BIOR250117P2000
- 1.51
- 0.000.00%
undefined Newsroom
Express News | Biora Therapeutics Inc - to File Motion for Approval of Marketing and Sale Process
Express News | Biora Therapeutics Inc - Secures up to $10.25 Million in Debtor in Possession Financing
Press Release: Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth
Express News | Biora Therapeutics Files for Chapter 11 Bankruptcy - Court Filing
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Why Biora Therapeutics (BIOR) Stock Is Down 45%
Dow Falls 150 Points; Oracle Posts Downbeat Results
Wall Street Set to Open Flat Tuesday as Investors Await Inflation Data
Top Premarket Decliners
Investors Look Ahead to Key Inflation Data as US Futures Tread Water in Tuesday's Premarket
Express News | Biora Therapeutics Inc - Nasdaq to Delist Biora Therapeutics Due to Non-Compliance
Express News | HC Wainwright & Co. Maintains Buy on Biora Therapeutics, Adjusts Price Target To $23 (1-10 Reverse Stock Split)
Biora Therapeutics Analyst Ratings
Express News | Biora Therapeutics Shares Are Trading Lower. The Stock May Be Moving on Continued Weakness Following a Q3 Earnings Miss and a Year-over-year Decline in Revenue Reported on Thursday
Biora Therapeutics | 10-Q: Q3 2024 Earnings Report
Biora Therapeutics | 8-K: Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Express News | Highbridge Capital Management, LLC Reports 9.99% Passive Stake in Biora Therapeutics Inc as of Sept 30, 2024- SEC Filing
Here Are the Major Earnings After the Close Today
Biora Therapeutics Reports Q3 EPS ($5.04) Vs (35c) Last Year
Earnings Flash (BIOR) BIORA THERAPEUTICS Posts Q3 Revenue $32,000